Home › Interstitial Lung Diseases › NCT07269262

SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers

Feasibility and Acceptability of a Mobile Application "SUPPORT-T" to Increase Equitable Access to Palliative Care in Patients With Progressive Pulmonary Fibrosis (PPF) and Their Caregivers

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Adults ≥18 years
* Confirmed diagnosis of PPF
* English or Spanish speaking

Caregiver Inclusion Criteria:

* adult, ≥ 18 years old
* Designated and identified by patient as providing most of the emotional, financial, and/or physical support (i.e., the individual most involved in care, does not have to live with patient)
* Able to speak and understand English.

Exclusion Criteria:

\-

About the study

This pilot randomized controlled trial evaluates the feasibility, acceptability, and accessibility of SUPPORT-T, a digitally delivered palliative care intervention for patients with Progressive Pulmonary Fibrosis (PPF) and their caregivers. The intervention includes a 9-week digital application guided by a nurse interventionist and quarterly virtual support groups over one year. Participants will be recruited from rural South Carolina and urban New York City. The study compares SUPPORT-T to Enhanced Usual Care and aims to inform a future multi-site trial.

What is being tested

• SUPPORT-T Educational Intervention (other)

Sponsor: Medical University of South Carolina · Participants: 170 · Started: Jan 13, 2026

Contact the study team

• Kathleen Lindell, PhD, RN, ATSF, FAAN · Phone: (843) 792-9763

Official record on ClinicalTrials.gov — NCT07269262

Locations in the U.S.

Conditions

• Interstitial Lung Diseases

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.